Literature DB >> 27660311

Clinical challenges in the diagnosis and management of postural tachycardia syndrome.

Pearl K Jones1, Brett H Shaw2, Satish R Raj3.   

Abstract

Postural tachycardia syndrome (POTS) is a multifactorial clinical syndrome defined by an increase in heart rate of ≥30 bpm on standing from supine position (or ≥40 bpm in children). It is associated with symptoms of cerebral hypoperfusion that are worse when upright and improve when in supine position. Patients often have additional symptoms including severe fatigue and difficulty concentrating. There are several possible pathophysiologic mechanisms including hypovolaemia, small-fibre peripheral neuropathy and hyperadrenergic states. POTS can also be associated with several disorders including mastocytosis, Ehlers-Danlos syndrome (hypermobility type) and autoimmune disorders. The treatment is focused on symptom relief and not solely on reducing tachycardia. Given its varying presentations, it is important to employ a practical, mechanism-focused approach to the diagnosis and management of POTS. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  AUTONOMIC; POTS; orthostatic intolerance; postural tachycardia syndrome; tachycardia

Mesh:

Year:  2016        PMID: 27660311     DOI: 10.1136/practneurol-2016-001405

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  6 in total

1.  Let's not forget about the vagus and other updates on recent autonomic research.

Authors:  Srikanth Muppidi; Mitchell G Miglis
Journal:  Clin Auton Res       Date:  2017-07-19       Impact factor: 4.435

2.  Autoimmune postural orthostatic tachycardia syndrome.

Authors:  Mari Watari; Shunya Nakane; Akihiro Mukaino; Makoto Nakajima; Yukiko Mori; Yasuhiro Maeda; Teruaki Masuda; Koutaro Takamatsu; Yanosuke Kouzaki; Osamu Higuchi; Hidenori Matsuo; Yukio Ando
Journal:  Ann Clin Transl Neurol       Date:  2018-02-28       Impact factor: 4.511

3.  The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey.

Authors:  B H Shaw; L E Stiles; K Bourne; E A Green; C A Shibao; L E Okamoto; E M Garland; A Gamboa; A Diedrich; V Raj; R S Sheldon; I Biaggioni; D Robertson; S R Raj
Journal:  J Intern Med       Date:  2019-04-16       Impact factor: 8.989

4.  gAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan.

Authors:  Makoto Yamakawa; Mari Watari; Ken-Ichi Torii; Ichiro Kuki; Masashi Miharu; Momoko Kawazu; Akihiro Mukaino; Osamu Higuchi; Yasuhiro Maeda; Tokunori Ikeda; Koutaro Takamatsu; Nozomu Tawara; Keiichi Nakahara; Hidenori Matsuo; Mitsuharu Ueda; Takao Takahashi; Shunya Nakane
Journal:  Ann Clin Transl Neurol       Date:  2021-02-23       Impact factor: 4.511

5.  Baroreflex sensitivity predicts therapeutic effects of metoprolol on pediatric postural orthostatic tachycardia syndrome.

Authors:  Yaxi Cui; Yuanyuan Wang; Ping Liu; Yuli Wang; Junbao Du; Hongfang Jin
Journal:  Front Cardiovasc Med       Date:  2022-09-14

6.  Sitting-induced hemodynamic changes and association with sitting intolerance in children and adolescents: a cross-sectional study.

Authors:  Chunyan Tao; Zhenhui Han; Yongqiang Yan; Zhitao Pan; Hanwen Zhu; Xueying Li; Hongxia Li; Yuanyuan Wang; Ping Liu; Yuli Wang; Min Jiang; Chaoshu Tang; Hongfang Jin; Junbao Du
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.